Valo Therapeutics Oy

Valo Therapeutics Oy focuses on solid tumours across several cancer types, with research activity spanning colorectal cancer, melanoma, non-small cell lung cancer, sarcoma, and triple negative breast cancer.

• Solid tumour immunotherapy
• Injectable tumour indications
• Cancer-specific antigen targeting

The sponsor’s clinical portfolio is centred on tumour-directed treatment approaches in oncology, with interest in malignancies that are often difficult to manage through conventional systemic therapy.